Marvell Technology has increased its fiscal year 2028 revenue target to $18 billion, raising the combined revenue expectations for FY2027 and FY2028 from about $20 billion to $30 billion. This growth is driven mainly by connectivity, switching, and storage segments, reducing reliance on custom silicon programs. The company has secured over 20 design wins for XPUs and expects custom ASIC revenue to reach $10–$11 billion by FY2029. Trading at a forward EV/EBITDA of 42.5x with a target of around 40% operating margins, Marvell is positioned competitively below peers like AMD and Astera Labs.
Stocks rebounded on Friday as oil prices fell, helping major indexes recover after several down sessions. Jim Cramer highlighted that the upcoming Federal Reserve meeting will be crucial, with investors watching how Treasury yields react to a potenti...
Marvell Technology's stock rose 5% following Piper Sandler's initiation of coverage with a $270 price target, citing the company's expanding role in AI data centers and custom silicon solutions. CEO Matt Murphy described Marvell as the "Switzerland o...
Qualcomm is rated as a Buy and Marvell as a Hold because Qualcomm offers a superior risk-adjusted upside despite Marvell having a stronger current AI business. Qualcomm's valuation is more forgiving of margin and execution misses, with a price target...
Marvell Technology posted a record Q2 revenue of $2.74 billion, driven by broad growth in data center products and customers. The company raised its revenue guidance for fiscal years 2027 and 2028, supported by strong demand for AI connectivity, cust...
Marvel Biosciences Corp. has received approval from the TSX Venture Exchange to extend the closing deadline for its private placement from August 31 to September 14, 2026. The company, which develops synthetic chemical derivatives of off-patent drugs...
